Alpha Rx

AlphaRx is an emerging pharmaceutical company specializing in the formulation of therapeutic products using proprietary drug delivery technologies. AlphaRx's core competent is in the development of novel drug formulations for compounds that are otherwise insoluble or poorly soluble in water. AlphaRx's technology is versatile and offers significant flexibility in the development of suitable dosage formulations (i.e. Immediate Release or Controlled Release) to meet the requirements of specific drug molecules. To date, AlphaRx has applied its Bioadhesive Colloidal Dispersion™ drug delivery technologies and formulation skills to the development of: Pain Control - topical and oral NSAID pharmaceuticals; oral Health Care - antimicrobial mouth rinse and toothpaste; Nutraceuticals - bioavailable dietary supplements; and Immnomodulators - heterocyclic cyclopentene derivatives with immunostimulating and anti-inflammatory activities.

Previous Forums
Date/Time		Forum
Jun 6 2002		Virtual Biotech Stocks Forum
May 22 2002		Biotech/Cardiology Stocks Virtual Forum

Market Assistant		PrecisionAlert
Earnings Data Annual Report		Enter your email address to receive alerts about this company